K N von Kaulla, E von Kaulla. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antithrombins/physiologyBlood Coagulation Disorders/drug therapyCoumarins/therapeutic useHeparin/administration & dosageHumansInjections, SubcutaneousProthrombin TimeThrombin/biosynthesisTime Factors
Substances: See more » AntithrombinsCoumarinsHeparinThrombin
Year: 1969 PMID: 5779813 DOI: 10.1055/s-0028-1111152
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628